Efficacy and Safety of Oral Non‐Statin Lipid‐Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta‐Analysis
ABSTRACT Introduction Dyslipidaemia remains a major contributor to atherosclerotic cardiovascular disease (ASCVD), and many patients fail to achieve recommended low‐density lipoprotein cholesterol (LDL‐C) targets despite statin therapy or are unable to tolerate statins. Oral non‐statin therapies have emerged as importa...